TFM
UNCY icon

TFC Financial Management’s Unicycive Therapeutics UNCY Stock Holding History

TFC Financial Management’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97K Hold
300
– – ﹤0.01% 537
2025
Q4 		$1.73K Hold
300
– – ﹤0.01% 541
2025
Q3 		$1.31K Buy
+300
New +$1.31K ﹤0.01% 601

Other funds holding UNCY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TFC Financial Management's UNCY Position: Q1 2026 in Review

TFC Financial Management held its Unicycive Therapeutics (UNCY) position steady in Q1 2026 at 300 shares worth $1.97K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

TFC Financial Management first reported a position in UNCY in Q3 2025 and has held it in 3 quarters since. 51 funds tracked by Wall St. Rank hold UNCY as of Q1 2026.

  • TFC Financial Management held 300 shares of Unicycive Therapeutics worth $1.97K as of Q1 2026.
  • TFC Financial Management left its Unicycive Therapeutics share count unchanged in Q1 2026.
  • Unicycive Therapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q1 2026, its #537 holding.
  • TFC Financial Management first reported a position in Unicycive Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 51 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q1 2026.

Based on TFC Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.